CNTA - Centessa Pharmaceuticals GAAP EPS of -$0.40 beats by $0.12
2023-11-14 02:09:59 ET
More on Centessa Pharmaceuticals
- Centessa Pharmaceuticals: A Diversified Bet In Underserved Markets
- Centessa Pharmaceuticals: Pipeline Progresses As PRESent-2 Initiated
- Morgan Stanley impressed with Centessa's lead candidate data at World Sleep Congress
- Seeking Alpha’s Quant Rating on Centessa Pharmaceuticals
- Historical earnings data for Centessa Pharmaceuticals
For further details see:
Centessa Pharmaceuticals GAAP EPS of -$0.40 beats by $0.12